FI831070A7 - Salisyylihappojohdannaisia, menetelmä niiden valmistamiseksi, näihin yhdisteisiin pohjautuvia farmaseuttisiavalmisteita sekä niiden käyttö. - Google Patents
Salisyylihappojohdannaisia, menetelmä niiden valmistamiseksi, näihin yhdisteisiin pohjautuvia farmaseuttisiavalmisteita sekä niiden käyttö. Download PDFInfo
- Publication number
- FI831070A7 FI831070A7 FI831070A FI831070A FI831070A7 FI 831070 A7 FI831070 A7 FI 831070A7 FI 831070 A FI831070 A FI 831070A FI 831070 A FI831070 A FI 831070A FI 831070 A7 FI831070 A7 FI 831070A7
- Authority
- FI
- Finland
- Prior art keywords
- compounds
- preparation
- acid derivatives
- salicylic acid
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823211934 DE3211934A1 (de) | 1982-03-31 | 1982-03-31 | Salicylsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI831070A0 FI831070A0 (fi) | 1983-03-29 |
| FI831070L FI831070L (fi) | 1983-10-01 |
| FI831070A7 true FI831070A7 (fi) | 1983-10-01 |
Family
ID=6159858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI831070A FI831070A7 (fi) | 1982-03-31 | 1983-03-29 | Salisyylihappojohdannaisia, menetelmä niiden valmistamiseksi, näihin yhdisteisiin pohjautuvia farmaseuttisiavalmisteita sekä niiden käyttö. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4542127A (enExample) |
| EP (1) | EP0090369B1 (enExample) |
| JP (1) | JPS58177974A (enExample) |
| KR (1) | KR840004080A (enExample) |
| AT (1) | ATE17350T1 (enExample) |
| AU (1) | AU1300383A (enExample) |
| CA (1) | CA1197240A (enExample) |
| DE (2) | DE3211934A1 (enExample) |
| DK (1) | DK149383A (enExample) |
| ES (1) | ES8401944A1 (enExample) |
| FI (1) | FI831070A7 (enExample) |
| GR (1) | GR79241B (enExample) |
| HU (1) | HU190445B (enExample) |
| MA (1) | MA19764A1 (enExample) |
| NO (1) | NO831170L (enExample) |
| NZ (1) | NZ203743A (enExample) |
| PT (1) | PT76473B (enExample) |
| ZA (1) | ZA832292B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312924A (en) | 1983-12-30 | 1994-05-17 | Dr. Karl Thomae Gmbh | Phenylacetic acid benzylamides |
| US5216167A (en) * | 1983-12-30 | 1993-06-01 | Dr. Karl Thomae Gmbh | Phenylacetic acid benzylamides |
| CN1597672A (zh) | 1998-07-24 | 2005-03-23 | 拜尔公司 | 取代的苯甲酰基环己二酮类化合物 |
| DE19920791A1 (de) * | 1999-05-06 | 2000-11-09 | Bayer Ag | Substituierte Benzoylisoxazole |
| DE19921424A1 (de) | 1999-05-08 | 2000-11-09 | Bayer Ag | Substituierte Benzoylketone |
| DE19946853A1 (de) * | 1999-09-30 | 2001-04-05 | Bayer Ag | Substituierte Arylketone |
| US7985743B1 (en) * | 2005-07-22 | 2011-07-26 | Gene A. Tabish | Topical pain reliever and method of making the same |
| MX2013000748A (es) | 2010-08-27 | 2013-03-05 | Gruenenthal Gmbh | 2-amino-quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3. |
| CA2804824A1 (en) | 2010-08-27 | 2012-03-01 | Gruenenthal Gmbh | Substituted quinoline-3-carboxamides as kcnq2/3 modulators |
| KR20130100300A (ko) | 2010-08-27 | 2013-09-10 | 그뤼넨탈 게엠베하 | Ｋｃｎｑ２／３ 조절제로서의 치환된 ２-옥시-퀴놀린-３-카복스아미드 |
| PL2609086T3 (pl) | 2010-08-27 | 2015-07-31 | Gruenenthal Gmbh | Podstawione 2-okso- i 2-tiookso-dihydrochinolino-3-karboksyamidy jako modulatory KCNQ2/3 |
| BR112013005056A2 (pt) | 2010-09-01 | 2016-05-31 | Gruenenthal Gmbh | 1-oxo-di-hidroisoquinolina-3-carboxamidas substituídas como moduladores kcnq2/3 |
| CA3256486A1 (en) * | 2022-04-25 | 2023-11-02 | Siteone Therapeutics, Inc. | Bicyclic Na V1.8 Heterocyclic Amide Inhibitors for Pain Management |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1185180B (de) * | 1963-10-19 | 1965-01-14 | Hoechst Ag | Verfahren zur Herstellung von Benzolsulfonylharnstoffen |
| DE2500157C2 (de) * | 1975-01-03 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung |
| DE2706977A1 (de) * | 1977-02-18 | 1978-08-24 | Hoechst Ag | Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung |
| EP0023569B1 (de) * | 1979-07-13 | 1983-06-22 | Dr. Karl Thomae GmbH | Carbonsäure-Derivate, deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE3100535A1 (de) * | 1981-01-10 | 1982-08-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | "neue carbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel" |
-
1982
- 1982-03-31 DE DE19823211934 patent/DE3211934A1/de not_active Withdrawn
-
1983
- 1983-03-21 KR KR1019830001272A patent/KR840004080A/ko not_active Withdrawn
- 1983-03-25 DE DE8383102983T patent/DE3361757D1/de not_active Expired
- 1983-03-25 EP EP83102983A patent/EP0090369B1/de not_active Expired
- 1983-03-25 AT AT83102983T patent/ATE17350T1/de not_active IP Right Cessation
- 1983-03-29 ES ES521082A patent/ES8401944A1/es not_active Expired
- 1983-03-29 PT PT76473A patent/PT76473B/pt unknown
- 1983-03-29 NO NO831170A patent/NO831170L/no unknown
- 1983-03-29 NZ NZ203743A patent/NZ203743A/en unknown
- 1983-03-29 FI FI831070A patent/FI831070A7/fi not_active Application Discontinuation
- 1983-03-29 GR GR70927A patent/GR79241B/el unknown
- 1983-03-29 US US06/479,906 patent/US4542127A/en not_active Expired - Fee Related
- 1983-03-30 CA CA000424930A patent/CA1197240A/en not_active Expired
- 1983-03-30 ZA ZA832292A patent/ZA832292B/xx unknown
- 1983-03-30 DK DK149383A patent/DK149383A/da not_active IP Right Cessation
- 1983-03-30 HU HU831092A patent/HU190445B/hu unknown
- 1983-03-30 AU AU13003/83A patent/AU1300383A/en not_active Abandoned
- 1983-03-30 JP JP58052808A patent/JPS58177974A/ja active Pending
- 1983-03-31 MA MA19984A patent/MA19764A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA832292B (en) | 1983-12-28 |
| EP0090369A1 (de) | 1983-10-05 |
| NZ203743A (en) | 1985-07-12 |
| FI831070L (fi) | 1983-10-01 |
| JPS58177974A (ja) | 1983-10-18 |
| ES521082A0 (es) | 1984-01-01 |
| HU190445B (en) | 1986-09-29 |
| EP0090369B1 (de) | 1986-01-08 |
| DE3211934A1 (de) | 1983-10-13 |
| CA1197240A (en) | 1985-11-26 |
| DK149383D0 (da) | 1983-03-30 |
| US4542127A (en) | 1985-09-17 |
| PT76473B (de) | 1986-01-24 |
| NO831170L (no) | 1983-10-03 |
| ES8401944A1 (es) | 1984-01-01 |
| ATE17350T1 (de) | 1986-01-15 |
| KR840004080A (ko) | 1984-10-06 |
| PT76473A (de) | 1983-04-01 |
| AU1300383A (en) | 1983-10-06 |
| MA19764A1 (fr) | 1983-10-01 |
| FI831070A0 (fi) | 1983-03-29 |
| DK149383A (da) | 1983-10-01 |
| GR79241B (enExample) | 1984-10-22 |
| DE3361757D1 (en) | 1986-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI830776A7 (fi) | Uudet yhdisteet, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkeaineena. | |
| FI820178A7 (fi) | Fosforyyliyhdisteet, menetelmä niiden valmistamiseksi, näitä yhdisteitä sisältävät farmaseuttiset valmisteetja niiden käyttö. | |
| FI823026A7 (fi) | Ureajohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkkeitä sekä näiden käyttö. | |
| FI843773A7 (fi) | Menetelmä sellaisten pitkitetyn vaikutuksen omaavien farmaseuttisten v almisteiden valmistamiseksi, joissa on korkea aktiivisen aineosan pito isuus. | |
| FI813349A7 (fi) | 1-Karboksialkanoyyli-indoliini-2- karboksyylihappoja, menetelmiä niiden valmistamiseksi, näitä yhdisteitsisältäviä farmaseuttisia valmisteita ja niiden terapeuttinen käyttö. | |
| FI803935A7 (fi) | Syklo-oktapeptidit ja niitä sisältävät farmaseuttiset valmisteet, menetelmä niiden valmistamiseksi ja niiden käyttö. | |
| FI802079A7 (fi) | Uudet syklopeptidit ja niistä tehdyt farmaseuttiset valmisteet, sekä menetelmä niiden valmistamiseksi. | |
| DE3669104D1 (de) | Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten. | |
| DE3480599D1 (de) | 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen. | |
| FI822178A7 (fi) | N-oksasyklyyli-alkyylipiperadiini- johdannaiset, menetelmä niiden valmistamiseksi, niitä sisältävät farmafarmaseuttiset valmisteet ja niiden käyttö. | |
| NL8300934A (nl) | Gesubstitueerde 1h-pyrazolo1,5-a-pyrimidinen, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten, die deze verbindingen bevatten. | |
| DK522983D0 (da) | Arylphenyletherderivater og syreadditionssalte deraf samt fremgangsmade til fremstilling deraf | |
| FI813422A7 (fi) | 1-Karboksi-atsa-alkanoyyli- indoliini- karboksyylihappoja, menetelmiä niiden valmistamiseksi, näitä yhdisteitsisältäviä farmaseuttisia valmisteita ja niiden terapeuttinen käyttö. | |
| FI824531A7 (fi) | N-oksidi-yhdisteet, menetelmä niiden valmistamiseksi ja näitä sisältävät farmaseuttiset valmisteet. | |
| FI820877A7 (fi) | Uudet tiatsolijohdannaiset, menetelmä niiden valmistamiseksi niitä sisältävät farmaseuttiset valmisteet ja nniiden käyttö. | |
| FI832291A7 (fi) | Ditio-yhdisteet, menetelmä niiden valmistamiseksi, niitä sisältävät farmaseuttiset valmisteet, ja niidenkäyttö. | |
| FI831926A7 (fi) | (+)-syanidan-3-olijohdannaisia sisältävät farmaseuttiset valmisteet ja niiden käyttö, uudet substituosubstituoidut (+)-syanidan-3-oli- johdannaiset ja menetelmät niiden vavalmistamiseksi. | |
| NL7901241A (nl) | Nieuwe gesubstitueerde 2-fenylimino-imidazolidinen, de zuuradditiezouten daarvan, farmaceutische preparaten die deze bevatten, alsmede werkwijze voor de bereiding daarvan. | |
| FI803202A7 (fi) | Fosfonohydroksietikkahappo, sen valmistusmenetelmä sekä käyttö lääkeaineena. | |
| FI821824A7 (fi) | Uusia karbasykliinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä. | |
| FI832467A7 (fi) | Difosfonihappo- johdannaisia ja näitä sisältäviä farmaseuttisia valmisteita. | |
| FI814175A7 (fi) | Tiatsoliinijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö sekä näihin yhdisteisiin perustuperustuvia farmaseuttisia valmisteita. | |
| FI873800A7 (fi) | Nor-kolaanihappojohdannaiset, menetelmä niiden valmistamiseksi, niiden käyttö sekä niitä sisältävät farmaseuttiset seokset. | |
| FI830898A7 (fi) | Sulfonyyliureoita, menetelmiä niiden valmistamiseksi, näihin yhdisteisiin pohjautuvia farmaseuttisia valmisvalmisteita sekä niiden käyttö. | |
| DE3670635D1 (de) | Neue benzisoselenazolonyl-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn [patent] |
Owner name: HOECHST AKTIENGESELLSCHAFT |